XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Activity
Restricted stock activity for the year ended December 31, 2021 and the nine months ended September 30, 2022 was as follows:
RSAWeighted Average Grant PricePRSUWeighted Average Grant PriceRSUWeighted Average Grant PriceTotalWeighted Average Grant Price
Nonvested balance as of January 1, 2021143,246 $23.04 39,570 $28.85 4,988 $24.08 187,804 $24.29 
Granted (1)
67,515 22.39 23,550 27.12 2,065 21.68 93,130 23.57 
Vested(61,384)22.26 — — (2,001)22.91 (63,385)22.28 
Forfeited(7,760)23.24 — — — — (7,760)23.24 
Nonvested balance as of December 31, 2021141,617 23.06 63,120 28.20 5,052 23.56 209,789 24.62 
Granted (1)
59,460 33.79 37,335 24.71 3,115 27.95 99,910 30.21 
Vested(57,934)23.29 (43,020)18.91 (2,062)23.20 (103,016)21.46 
Forfeited(4,701)26.50 — — — — (4,701)26.50 
Nonvested balance as of September 30, 2022138,442 $27.46 57,435 $32.89 6,105 $25.92 201,982 $28.95 
Unrecognized compensation cost (in thousands)$2,880 $1,046 $105 $4,031 
Weighted average remaining recognition period (in years)2.481.811.912.29
(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved related to the performance based restricted stock units. The number of shares actually issued may vary. During the nine months ended September 30, 2022, an additional 21,510 were issued related to actual performance results of previously granted awards.
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2022202120222021
(In Thousands)
Share-based compensation expense$651 $578 $1,905 $1,716